Skip to content

Effects of Peripheral Inflammation on Brain Functional Connectome Alterations in Knee Osteoarthritis Patients Based on Resting-State fMRI and Inflammatory Factors

Effects of Peripheral Inflammation on Brain Functional Connectome Alterations in Knee Osteoarthritis Patients Based on Resting-State fMRI and Inflammatory Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119530
Enrollment
Unknown
Registered
2026-02-28
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Knee osteoarthritis (KOA) patients:No intervention (observational study)
Healthy controls:No intervention (observational study)

Sponsors

Yancheng Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria of KOA patients: (1) Diagnosis of KOA according to the American College of Rheumatology (ACR) criteria; (2) Radiographic severity graded as Kellgren-Lawrence (KL) grade >= II; (3) Pain intensity >= 3 on a 0-10 Numeric Rating Scale (NRS); (4) Duration of knee pain >= 3 months; (5) Aged between 45 and 70 years; (6) Right-handed; (7) No history of cognitive impairment, psychiatric disorders, or neurological diseases; 2. Inclusion criteria of HCs: (1) No history of knee pain, arthritis, or other chronic pain disorders; (2) Matched to KOA patients by age and sex; (3) Right-handed; (4) Knee joint X-ray films show a Kellgren-Lawrence (KL) grade <= ? (or no definite radiological evidence of osteoarthritis); (5) No history of cognitive impairment, mental illness, or central nervous system diseases, and ability to cooperate with resting-state functional magnetic resonance imaging (rs-fMRI) scanning and various assessments; (6) No use of non-steroidal anti-inflammatory drugs (NSAIDs), opioids, or other drugs affecting central pain processing within 1 month prior to enrollment; (7) No contraindications to magnetic resonance imaging (MRI) examination (e.g., metallic implants, claustrophobia, etc.); (8) Ability to understand and sign the written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria of KOA patients: (1) History of knee surgery within the previous 6 months; (2) Presence of other inflammatory arthritis, fibromyalgia, or other chronic pain conditions; (3) Major psychiatric disorders or neurological diseases; (4) Severe systemic comorbidities;(5) Use of centrally acting analgesics, opioids, benzodiazepines, or antidepressants within 2 weeks before scanning; (6) Excessive head motion during fMRI acquisition (> 2 mm translation or > 2° rotation); (7) Structural brain abnormalities. (8) MRI contraindications. 2. Exclusion criteria of HCs: (1) History of systemic inflammatory diseases, traumatic knee injury, or chronic pain; (2) Major physical, psychiatric, neurological, or cognitive disorders; (3) Use of centrally acting medications within 2 weeks before MRI scanning; (4) MRI contraindications or structural brain abnormalities detected on MRI; (5) Head motion > 2 mm translation or > 2° rotation during MRI scanning.

Design outcomes

Primary

MeasureTime frame
Characteristics of brain functional connectome in KOA patients;

Secondary

MeasureTime frame
Peripheral inflammatory factor levels;

Countries

China

Contacts

Public ContactShu Wang

Yancheng Third People's Hospital

ycsyws@126.com+86 151 8920 0649

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026